PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
 
Br J Cancer. 1990 May; 61(5): 779–787.
PMCID: PMC1971597

Adjuvant chemotherapy in head and neck cancer.

Abstract

An overview is presented of 23 trials of adjuvant chemotherapy in squamous cell carcinoma of the head and neck. These were reviewed from the point of view of design of the trial, analysis of survival, response rates, meta-analysis, site of failure, toxicity and cost. The minimal increase in survival that could be detected ranged from 11 to 51%, with a median of 25%. No trial was big enough to detect the likely increase of survival, which is 5%. Many trials excluded some eligible patients before randomisation, the proportion being 21% in those series with details. A further 9% of treated patients were excluded from analysis. A response rate in four induction studies of 47% equated with a 6% increase in cancer mortality. Meta-analysis showed an insignificant overall improvement in cancer mortality of 0.5%. Induction chemotherapy, synchronous chemotherapy and induction/maintenance chemotherapy did not affect cancer mortality whereas synchronous/maintenance therapy did. Cisplatinum, methotrexate, bleomycin, 5-FU and a variety of other regimens did not affect the death rate from cancer, but the combination of VBM significantly increased it. Neither single agent nor combination chemotherapy produced a significant reduction of cancer deaths. The rate of locoregional failure was significantly lower in the treated arms, whereas the metastatic rate was similar in both arms. Only three papers gave full details of toxicity with grading: these showed a high toxicity rate. The mortality rate from chemotherapy in nine series averaged 6.5%.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Arcangeli G, Nervi C, Righini R, Creton G, Mirri MA, Guerra A. Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol. 1983 Nov;1(2):101–107. [PubMed]
  • Bakowski MT, Macdonald E, Mould RF, Cawte P, Sloggem J, Barrett A, Dalley V, Newton KA, Westbury G, James SE, et al. Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):115–119. [PubMed]
  • Bulpitt CJ. Subgroup analysis. Lancet. 1988 Jul 2;2(8601):31–34. [PubMed]
  • Cachin Y, Jortay A, Sancho H, Eschwege F, Madelain M, Desaulty A, Gerard P. Preliminary results of a randomized E.O.R.T.C. study comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx. Eur J Cancer. 1977 Dec;13(12):1389–1395. [PubMed]
  • Cachin Y. Adjuvant chemotherapy in head and neck carcinoma. Clin Otolaryngol Allied Sci. 1982 Apr;7(2):121–132. [PubMed]
  • Chang TM. Induction chemotherapy for advanced head and neck cancers: a literature review. Head Neck Surg. 1988 Jan-Feb;10(3):150–159. [PubMed]
  • Fazekas JT, Sommer C, Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Int J Radiat Oncol Biol Phys. 1980 May;6(5):533–541. [PubMed]
  • FLETCHER GH, SUIT HD, HOWE CD, SAMUELS M, JESSE RH, Jr, VILLAREAL RU. Clinical method of testing radiation-sensitizing agents in squamous cell carcinoma. Cancer. 1963 Mar;16:355–363. [PubMed]
  • Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet DR, Chun C, Friedman MA, Kohler M, McWhirter K, Carter SK. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol. 1987 Sep;5(9):1410–1418. [PubMed]
  • Glick JH, Taylor SG., 4th Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: a review. Int J Radiat Oncol Biol Phys. 1981 Feb;7(2):229–242. [PubMed]
  • Gollin FF, Ansfield FJ, Brandenburg JH, Ramirez G, Vermund H. Combined therapy in advanced head and neck cancer: a randomized study. Am J Roentgenol Radium Ther Nucl Med. 1972 Jan;114(1):83–88. [PubMed]
  • Gupta NK, Pointon RC, Wilkinson PM. A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol. 1987 Nov;38(6):575–581. [PubMed]
  • Holoye PY, Grossman TW, Toohill RJ, Kun LE, Byhardt RW, Duncavage JA, Teplin RW, Ritch PS, Hoffman RG, Malin TC. Randomized study of adjuvant chemotherapy for head and neck cancer. Otolaryngol Head Neck Surg. 1985 Dec;93(6):712–717. [PubMed]
  • Hong WK. Induction chemotherapy for advanced head and neck cancer. Head Neck Surg. 1988 Jan-Feb;10(3):147–149. [PubMed]
  • Hussey DH, Abrams JP. Combined therapy in advanced head and neck cancer: hydroxyurea and radiotherapy. Prog Clin Cancer. 1975;6:79–86. [PubMed]
  • Johnson JT, Myers EN, Srodes CH, Mayernik DG, Sigler BA, Schramm VL, Jr, Nolan TA, Wagner RL. Maintenance chemotherapy for high-risk patients. A preliminary report. Arch Otolaryngol. 1985 Nov;111(11):727–729. [PubMed]
  • Kapstad B, Bang G, Rennaes S, Dahler A. Combined preoperative treatment with cobalt and bleomycin in patients with head and neck carcinoma--a controlled clinical study. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):85–89. [PubMed]
  • Knowlton AH, Percarpio B, Bobrow S, Fischer JJ. Methotrexate and radiation therapy in the treatment of advanced head and neck tumors. Radiology. 1975 Sep;116(3):709–712. [PubMed]
  • Lo TC, Wiley AL, Jr, Ansfield FJ, Brandenburg JH, Davis HL, Jr, Gollin FF, Johnson RO, Ramirez G, Vermund H. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. AJR Am J Roentgenol. 1976 Feb;126(2):229–235. [PubMed]
  • Mead GM, Jacobs C. Changing role of chemotherapy in treatment of head and neck cancer. Am J Med. 1982 Oct;73(4):582–595. [PubMed]
  • Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. [PubMed]
  • Morton RP, Rugman F, Dorman EB, Stoney PJ, Wilson JA, McCormick M, Veevers A, Stell PM. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. Cancer Chemother Pharmacol. 1985;15(3):283–289. [PubMed]
  • Nissenbaum M, Browde S, Bezwoda WR, de Moor NG, Derman DP. Treatment of advanced head and neck cancer: multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach. Med Pediatr Oncol. 1984;12(3):204–208. [PubMed]
  • Pearlman NW, Johnson FB, Braun TJ, Kennaugh RC, Spofford BF, Borlase BC, Meyer TJ, Stiegmann GV, Meyers AD. A prospective study of preoperative chemotherapy and split-course irradiation for locally advanced or recurrent oral/pharyngeal squamous carcinoma. Am J Clin Oncol. 1985 Dec;8(6):490–496. [PubMed]
  • Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 1987 Apr-May;6(3):233–244. [PubMed]
  • Petrovich Z, Block J, Kuisk H, Mackintosh R, Casciato D, Jose L, Barton R. A randomized comparison of radiotherapy with a radiotherapy--chemotherapy combination in stage IV carcinoma of the head and neck. Cancer. 1981 May 1;47(9):2259–2264. [PubMed]
  • Rentschler RE, Wilbur DW, Petti GH, Chonkich GD, Hilliard DA, Camacho ES, Thorpe RB. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas--a prospective, randomized study. J Clin Oncol. 1987 Feb;5(2):278–285. [PubMed]
  • Richards GJ, Jr, Chambers RG. Hydroxyurea: a radiosensitizer in the treatment of neoplasms of the head and neck. Am J Roentgenol Radium Ther Nucl Med. 1969 Mar;105(3):555–565. [PubMed]
  • Schuller DE, Metch B, Stein DW, Mattox D, McCracken JD. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope. 1988 Nov;98(11):1205–1211. [PubMed]
  • Schuller DE, Stein DW, Metch B. Analysis of treatment failure patterns. A Southwest Oncology Group Study. Arch Otolaryngol Head Neck Surg. 1989 Jul;115(7):834–836. [PubMed]
  • Shanta V, Krishnamurthi S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiol. 1980 Sep;31(5):617–620. [PubMed]
  • Stefani S, Eells RW, Abbate J. Hydroxyurea and radiotherapy in head and neck cancer. Results of a prospective controlled study in 126 patients. Radiology. 1971 Nov;101(2):391–396. [PubMed]
  • Stell PM, Dalby JE, Strickland P, Fraser JG, Bradley PJ, Flood LM. Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol. 1983 Jul;34(4):463–467. [PubMed]
  • Stell PM. Can we afford to treat head and neck cancer? Clin Otolaryngol Allied Sci. 1987 Oct;12(5):321–325. [PubMed]
  • Stolwijk C, Wagener DJ, Van den Broek P, Levendag PC, Kazem I, Bruaset I, De Mulder PH. Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Neth J Med. 1985;28(9):347–351. [PubMed]
  • Tannock IF, Browman G. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol. 1986 Jul;4(7):1121–1126. [PubMed]
  • Taylor SG, 4th, Applebaum E, Showel JL, Norusis M, Holinger LD, Hutchinson JC, Jr, Murthy AK, Caldarelli DD. A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol. 1985 May;3(5):672–679. [PubMed]
  • Toohill RJ, Anderson T, Byhardt RW, Cox JD, Duncavage JA, Grossman TW, Haas CD, Haas JS, Hartz AJ, Libnoch JA, et al. Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report. Arch Otolaryngol Head Neck Surg. 1987 Jul;113(7):758–761. [PubMed]
  • Vermund H, Kaalhus O, Winther F, Trausjø J, Thorud E, Harang R. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys. 1985 Nov;11(11):1877–1886. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK